During the past decade, Hospital Governador Celso Ramos conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Governador Celso Ramos" #1 collaborator was "Ministry of Health, Brazil" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Governador Celso Ramos" are "Blind Painful Eye" (1 trials), "Blood Pressure" (1 trials), "Cognitive Impairment" (1 trials), "Control of Pain Through Drug Injection" (1 trials) and "Ischemic Stroke" (1 trials). Many other conditions were trialed in "Hospital Governador Celso Ramos" in a lesser frequency.

Most popular intervention types in "Hospital Governador Celso Ramos" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Chlorpromazine" (1 trials), "Intensive Control of Systolic Blood Pressure (SBP)" (1 trials), "Standard control of Systolic Blood Pressure (SBP)" (1 trials) and "Triamcinolone" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Governador Celso Ramos" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Hospital Governador Celso Ramos". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Hospital Governador Celso Ramos, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Governador Celso Ramos, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".